GMP Produced Rabies Vaccine Vero Cell Preparation

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides professional vaccine manufacturing solutions for global healthcare partners. The GMP Produced Rabies Vaccine Vero Cell Preparation is developed through standardized biopharmaceutical production procedures, combining Vero cell culture technology, purification processes, and freeze-drying technology to create a stable human rabies vaccine preparation. The product is designed for professional immunization programs requiring reliable quality management and consistent supply capability.

Product Overview

Human rabies prevention requires reliable vaccine products supported by professional manufacturing processes and strict quality control. AIM Honor focuses on vaccine research, development, and manufacturing capability to provide dependable solutions for healthcare organizations and international distributors.

The GMP Produced Rabies Vaccine Vero Cell Preparation is a freeze-dried inactivated rabies vaccine produced using rabies fixed virus (aGV strain) cultivated in Vero cells. The manufacturing process includes virus cultivation, inactivation, concentration, purification, formulation, and lyophilization procedures to maintain product quality and stability.

The vaccine appears as a white freeze-dried cake before reconstitution. After adding sterile water for injection, it becomes a clear liquid suitable for intramuscular injection according to professional medical guidance.

Composition And Features

The vaccine formulation uses inactivated rabies fixed virus as the active ingredient. During preparation, stabilizing components are added to maintain product characteristics throughout storage and transportation.

The main composition includes:

1. Active ingredient: Inactivated rabies fixed virus.

2. Stabilizing components: Human albumin, gelatin, and sucrose.

3. Diluent: Sterile water for injection.

The product does not contain preservatives according to the provided product information, supporting customers who require controlled vaccine formulations for professional applications.

Technical Specifications

AIM Honor applies standardized production management throughout the vaccine manufacturing process. The following specifications are based on the original product information provided for Rabies Vaccine Vero Cell.

GMP Manufacturing

The production quality of a vaccine depends on controlled manufacturing environments, standardized procedures, and strict quality monitoring. AIM Honor completes vaccine production through professional facilities and controlled processes designed to maintain consistency throughout each manufacturing stage.

The key production advantages include:

1. Advanced purification technology: The production process adopts a 20m² ultrafiltration system and a 600mm chromatography system for multi-step purification. These processes help remove foreign proteins, DNA, and other impurities while maintaining antigen quality.

2. Strict quality management: AIM Honor applies controlled internal quality standards, including endotoxin control ≤10EU/dose, sterility testing, and pH value monitoring to support stable product performance.

3. Professional freeze-drying process: A 40m² freeze-drying system is used during preparation. This process helps reduce moisture content, maintain antigen activity, and improve product stability during storage.

Manufacturing Comparison

For pharmaceutical buyers, understanding production differences helps identify reliable vaccine suppliers. The following comparison highlights the manufacturing characteristics of AIM Honor’s vaccine preparation compared with general vaccine products.

Application Areas

The GMP Produced Rabies Vaccine Vero Cell Preparation is designed for professional human rabies prevention programs. With Vero cell culture technology and controlled manufacturing procedures, the product can support different vaccination requirements in healthcare environments.

Typical application scenarios include:

1. Post-exposure vaccination: Individuals bitten or scratched by suspected rabid animals may require timely medical evaluation and vaccination according to professional guidance. Immediate wound cleaning and appropriate vaccination procedures are important parts of rabies exposure management.

2. Pre-exposure vaccination: People with a higher possibility of contacting rabies virus during work activities may require preventive immunization. These groups can include veterinarians, animal breeders, forestry workers, slaughterhouse workers, and rabies laboratory personnel.

3. Healthcare supply programs: Medical institutions, vaccine distributors, and healthcare organizations can cooperate with AIM Honor for professional vaccine procurement and supply support.

Immunization Guidance

The vaccination process should be performed by qualified medical professionals according to individual conditions and applicable immunization procedures. The product is intended for intramuscular injection after proper reconstitution.

Preparation Method

Before administration, the freeze-dried vaccine should be reconstituted with the enclosed sterile water for injection according to the product instructions. The container should be shaken thoroughly after adding the diluent.

Injection Method

The vaccine is administered through intramuscular injection. For adults and older children, the recommended injection site is the deltoid muscle of the upper arm. For young children, the vaccine may be administered in the anterolateral thigh muscle according to professional medical guidance.

Post Exposure Schedule

The recommended post-exposure vaccination schedule includes administration on days 0, 3, 7, 14, and 28, with five doses in total. The vaccination procedure should be adjusted according to medical assessment and exposure classification.

For different exposure categories:

Category I: Contact with animals without broken skin exposure generally does not require vaccine administration according to the provided product information.

Category II: Bites or scratches without bleeding require vaccination according to the post-exposure schedule.

Category III: Exposure involving bleeding wounds, mucous membrane contamination, or broken skin contact with saliva from suspected rabid animals requires immediate medical management, including vaccination and other recommended medical treatments.

Quality Control

AIM Honor focuses on maintaining consistent product quality through professional manufacturing management and multiple control procedures. The vaccine production process includes controlled cultivation, purification, formulation, freeze-drying, and testing procedures.

Key quality management procedures include:

1. Sterile production environment: The bacterial culture and passage processes are completed in a closed sterile operation system under a B+A grade clean environment.

2. Controlled cell expansion: High-precision equipment is used to monitor important production parameters such as temperature and pH, helping maintain stable strain activity and cell proliferation.

3. Purification and testing: Multiple purification and quality testing procedures are applied to support product purity, consistency, and stability.

Storage And Supply

Proper storage and transportation conditions are important for maintaining vaccine quality. The product should be stored and transported between +2 °C and +8 °C and protected from light.

Under recommended storage conditions, the validity period of the product is 36 months. AIM Honor supports professional cooperation with international customers requiring stable vaccine supply solutions.

Why Choose AIM Honor

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on vaccine research, development, manufacturing, and global cooperation. The company provides professional biopharmaceutical production capability supported by standardized manufacturing procedures and quality management systems.

Customers choosing AIM Honor can benefit from:

1. Professional manufacturing experience: AIM Honor focuses on vaccine production and applies advanced biopharmaceutical technologies.

2. Reliable production management: Controlled manufacturing processes help maintain product consistency and quality stability.

3. International cooperation support: The company provides professional communication and supply assistance for qualified global partners.

FAQ

Q: What are the specifications of this rabies vaccine?

A: According to the product information, the vaccine provides 1.0ml per vial after reconstitution, with potency not less than 2.51U. The product should be stored between +2 °C and +8 °C and has a validity period of 36 months.

Q: Is this vaccine suitable for pre-exposure and post-exposure vaccination?

A: The product is intended for human rabies prevention and can be used according to professional vaccination procedures for different exposure situations, including preventive vaccination and vaccination after exposure.

Q: Does the vaccine contain preservatives?

A: According to the provided product information, the vaccine does not contain preservatives. The formulation includes inactivated rabies fixed virus, human albumin, gelatin, sucrose, and sterile water for injection.

Q: How should this vaccine be stored during transportation?

A: The vaccine should be transported and stored between +2 °C and +8 °C while being protected from light to maintain product quality.

Q: Can AIM Honor provide bulk supply cooperation?

A: AIM Honor provides professional cooperation services for qualified international customers, including vaccine distributors, healthcare organizations, and medical partners seeking stable rabies vaccine supply.

Conclusion

With GMP controlled manufacturing procedures, Vero cell culture technology, advanced purification processes, and professional quality management, AIM Honor’s GMP Produced Rabies Vaccine Vero Cell Preparation provides a reliable human rabies vaccine solution for global healthcare partners. The combination of manufacturing capability, technical expertise, and stable supply support makes AIM Honor a trusted partner for customers seeking professional rabies vaccine procurement solutions.